OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications
Miguel Á. Ortega, Diego Liviu Boaru, Diego De León-Oliva, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 8, pp. 987-1000
Closed Access | Times Cited: 13
Miguel Á. Ortega, Diego Liviu Boaru, Diego De León-Oliva, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 8, pp. 987-1000
Closed Access | Times Cited: 13
Showing 13 citing articles:
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 8
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 8
Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 5
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 5
Rapid and Differential Diagnosis of Sepsis Stages Using an Advanced 3D Plasmonic Bimetallic Alloy Nanoarchitecture‐Based SERS Biosensor Combined with Machine Learning for Multiple Analyte Identification
Woo Hyun Kim, Sungwoo Lee, Myeong Jin Jeon, et al.
Advanced Science (2025)
Open Access
Woo Hyun Kim, Sungwoo Lee, Myeong Jin Jeon, et al.
Advanced Science (2025)
Open Access
Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products
Dongyang Li, Xingguo Lan, Linyi Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dongyang Li, Xingguo Lan, Linyi Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Is it time to revisit the significance of PD-L1 expression in assisting our treatment decisions?
Georgios Papageorgiou, Nikolaos Skouteris, Maria Grenzelia, et al.
Immunotherapy (2025), pp. 1-5
Closed Access
Georgios Papageorgiou, Nikolaos Skouteris, Maria Grenzelia, et al.
Immunotherapy (2025), pp. 1-5
Closed Access
Mechanisms and Functional Implications of ZDHHC5 in Cellular Physiology and Disease
Huicong Liu, Shuo Wen, Chang Xu, et al.
Journal of Lipid Research (2025), pp. 100793-100793
Open Access
Huicong Liu, Shuo Wen, Chang Xu, et al.
Journal of Lipid Research (2025), pp. 100793-100793
Open Access
Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
José M. García, Vanesa Gutiérrez, A. Cantero, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2499-2499
Open Access
José M. García, Vanesa Gutiérrez, A. Cantero, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2499-2499
Open Access
Programmed death-ligand 1 regulates ameloblastoma growth and recurrence
Linzhou Zhang, Hao Lin, Jiajie Liang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Linzhou Zhang, Hao Lin, Jiajie Liang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Targeted protein degradation with small molecules for cancer immunotherapy
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
Small Molecule Inhibitors Targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for Cancer Immunotherapy (2020-2024)
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2
Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer
Xiangdong Liu, Wanqiu Zhang, Shaozhong Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Xiangdong Liu, Wanqiu Zhang, Shaozhong Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials
Zhen-Zi Wang, Yuan Liu, Kedi Wang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Zhen-Zi Wang, Yuan Liu, Kedi Wang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Comparative efficacy of targeted therapies and immunotherapy in advanced non-small cell lung cancer: a systematic review
Byron Cristobal Llongo Cali, Jorge Eduardo Paredes Jaramillo, Jennifer Alicia Álvarez Navas, et al.
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 9, pp. 3384-3393
Open Access
Byron Cristobal Llongo Cali, Jorge Eduardo Paredes Jaramillo, Jennifer Alicia Álvarez Navas, et al.
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 9, pp. 3384-3393
Open Access
Myeloid‐derived suppressor cells inhibit responses of T follicular helper cells during experimental Plasmodium yoelii infection
Lengshan Mo, Cansheng Hong, Zi-Bin Jiang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 23
Closed Access
Lengshan Mo, Cansheng Hong, Zi-Bin Jiang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 23
Closed Access
